Research output per year
Research output per year
-
Filgotinib bei Colitis ulcerosa: ein Review
Translated title of the contribution :Filgotinib in Ulcerative Colitis: a review Research output: Contribution to journal › Article › peer-review
Open Access -
FRI-394 High burden of cirrhosis and increasing response rates to bulevirtide-based regimens: insights from the austrian prospective hepatitis D registry
Schwarz, M., Schwarz, C., Bauer, D., Panzer, M., Strasser, M., Reiter, S., Moschen, A. & et al., Jun 2024, 2 p.Research output: Other contribution
-
Gut Microbiome, Obesity, and Metabolic Syndrome
Tilg, H. & Moschen, A., Jan 2024, Metabolic Syndrome: A Comprehensive Textbook. p. 373-384 12 p.Research output: Chapter in Book/Report/Conference proceeding › Chapter › peer-review
-
Long-Term Follow-Up After Non-Curative Endoscopic Submucosal Dissection for Early Gastrointestinal Cancer—A Retrospective Multicenter Analysis
Pimingstorfer, P., Gregus, M., Ziachehabi, A., Moschen, A., Függer, R. & Schöfl, R., 02 Nov 2024, In: Journal of Clinical Medicine. 13, 21, 1 p., 6594.Research output: Contribution to journal › Article › peer-review
Open Access -
P206 Metabolomic predictors of response to vedolizumab in Inflammatory Bowel Disease
Reider, S., Watschinger, C., Koch, R., Tilg, H. & Moschen, A., Jan 2024, In: Journal of Crohn's and Colitis. 18, 1 p.Research output: Contribution to journal › Article › peer-review
-
VICTRIVA: A Randomized, Double-blind, Phase 3b Study to Evaluate the Short- and Long-term Efficacy and Safety of Dual Targeted Therapy With lntravenous Vedolizumab and Oral Upadacitinib Compared With lntravenous Vedolizumab and Oral Placebo for lnduction Followed by lntravenous Vedolizumab Monotherapy for Maintenance in the Treatment of Adults With Moderately to Severely Active Crohn's Disease
Moschen, A. (PI), Prommer, R. (Co-PI), Klenske, E. (Researcher), Pimingstorfer, P. (Researcher), Rathenböck, M. D. (Researcher), Kainberger, M. (Administration) & Zaunmair, P. (Administration)
28.03.2025 → 27.03.2030
Project: Clinical studies › Clinical Study (Industry project)
-
Roche_NK cells in IBD
Moschen, A. (PI)
14.01.2021 → 14.01.2022
Project: Funded research › Other sponsors
-
Pregnancy in IBD – anything new regarding the new kids in town?
Moschen, A. (Speaker)
29 Aug 2025Activity: Talk or presentation › Invited talk › science-to-science
-
Klinik – Warum anti-IL23? … bei Colitis ulcerosa
Moschen, A. (Speaker)
27 Jun 2025Activity: Talk or presentation › Invited talk › science-to-science
-
IBD medical education meeting - Johnson & Johnson
Moschen, A. (Participant)
12 Jun 2025 → 14 Jun 2025Activity: Participating in or organising an event › Participating in a conference, workshop, ...
-
Eular 2025
Moschen, A. (Participant), Schmidt, A.-M. (Participant) & Öberseder, G. (Participant)
11 Jun 2025Activity: Participating in or organising an event › Participating in a conference, workshop, ...
-
Commercial Advisory Board - Johnson & Johnson
Moschen, A. (Participant)
29 May 2025Activity: Participating in or organising an event › Participating in a conference, workshop, ...